MX9604553A - Low dosage ranitidine compositions for the treatment of minor gastrointestinal disorders associated with excess acid secretion. - Google Patents
Low dosage ranitidine compositions for the treatment of minor gastrointestinal disorders associated with excess acid secretion.Info
- Publication number
- MX9604553A MX9604553A MX9604553A MX9604553A MX9604553A MX 9604553 A MX9604553 A MX 9604553A MX 9604553 A MX9604553 A MX 9604553A MX 9604553 A MX9604553 A MX 9604553A MX 9604553 A MX9604553 A MX 9604553A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- low dosage
- disorders associated
- gastrointestinal disorders
- acid secretion
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention relates to low dosage formulations containing the histamine H2-receptor antagonist ranitidine and their use in the treatment of gastric disorders such as episodic heartburn.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9407235.2 | 1994-04-12 | ||
GB9407235A GB9407235D0 (en) | 1994-04-12 | 1994-04-12 | Pharmaceutical compositions |
PCT/EP1995/001271 WO1995027486A1 (en) | 1994-04-12 | 1995-04-10 | Low dosage ranitidine compositions for the treatment of minor gastrointestinal disorders associated with excess acid secretion |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9604553A true MX9604553A (en) | 1997-11-29 |
MXPA96004553A MXPA96004553A (en) | 1998-07-03 |
Family
ID=
Also Published As
Publication number | Publication date |
---|---|
AU2138095A (en) | 1995-10-30 |
CA2187651A1 (en) | 1995-10-19 |
AU690664B2 (en) | 1998-04-30 |
WO1995027486A1 (en) | 1995-10-19 |
ZA952931B (en) | 1996-01-05 |
EP0755251A1 (en) | 1997-01-29 |
GB9407235D0 (en) | 1994-06-08 |
NZ283354A (en) | 1998-08-26 |
BR9507312A (en) | 1997-10-07 |
CN1146150A (en) | 1997-03-26 |
JPH10502331A (en) | 1998-03-03 |
KR970702034A (en) | 1997-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60018100D1 (en) | Polymorphe form von atorvastatin-calcium | |
PL300194A1 (en) | Interferon conjugate, method of obtaining same and pharmaceutical composition containing it | |
EP0935417A4 (en) | Enteric formulations of proanthocyanidin polymer antidiarrheal compositions | |
HK1024865A1 (en) | Pharmaceutical compositions comprising a mixture of autocross-linked hyaluronic acid and nonautocross-linked hyaluronic acid and their use for the treatment of arthropathies | |
IL152659A (en) | Liquid pharmaceutical compositions comprising a pegylated human erythropoietin protein and a multiple charged inorganic anion, in a pharmaceutically acceptable buffer | |
IL136591A (en) | Nasal pharmaceutical solutions | |
TR200102648T2 (en) | Compositions that support growth | |
YU20003A (en) | Fused heterocyclic succinamide compounds and analogs thereof, modulators of nuclear hormone receptor function | |
NZ247201A (en) | Substituted sulphonylamido- or sulphonamidocarbonyl-pyridine-2-carboxamide derivatives and pharmaceutical compositions | |
ZA937544B (en) | Pharmaceutical compositions | |
HUP0100090A2 (en) | Oral care composition | |
ZA943744B (en) | Therapeutic substituted guanidines | |
WO2000011000A3 (en) | New compounds | |
SE9401197D0 (en) | Active compounds | |
AP2001002191A0 (en) | 3,3- Biarylpiperine and 2,2-biarylmorpholine derivatives. | |
WO2000010999A3 (en) | New compounds | |
DE3479290D1 (en) | Synergistic composition comprising gamma interferon and lymphotoxin, and its preparation | |
NZ326345A (en) | Composition containing diosgenin | |
IL67940A0 (en) | 2,3-diaryl-5-halo-thiophenes,their preparation and pharmaceutical compositions containing them | |
BG103306A (en) | Liquid allendronate compositions | |
MX9604553A (en) | Low dosage ranitidine compositions for the treatment of minor gastrointestinal disorders associated with excess acid secretion. | |
UA42722C2 (en) | Sulphides, sulphoxides and sulphones or the pharmaceutically acceptable salts thereof and pharmaceutical composition containing them | |
IL111805A0 (en) | Pharmaceutical compositions comprising dimeticone for the treatment of aphthae | |
SI1196129T1 (en) | Pharmaceutical and cosmetic compositions comprising urocanic acid derivatives as radical scavengers or antioxidants | |
ES8105975A1 (en) | Carbamates, their preparation and pharmaceutical compositions containing them. |